fe.novak
Submits third-party assay reports on material purchased directly. Based in Malmö.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.60%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041837 | Survodutide | GSP | GSP-2603-E3156 | Janoshik | 2026-Q3 | 98.33 | 5.37 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043203 | GHK-Cu | SGN | SGN-2603-X8452 | Medutest | 2026-Q2 | 98.53 | 3.88 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042034 | Semaglutide | HYB | HYB-2511-F6451 | Janoshik | 2026-Q2 | 98.59 | 1.83 | 95.7 | Buyer-sourced | 0 | PASS |
| AX-2025-020237 | Retatrutide | GGPeps | GGPE-2508-E1731 | Kestrel | 2025-Q3 | 98.61 | 1.92 | 106.7 | Buyer-sourced | 1 | FAIL |
| AX-2025-019151 | NAD+ | GSP | GSP-2503-B3620 | Janoshik | 2025-Q3 | 99.74 | 9.26 | 94.8 | Buyer-sourced | 0 | PASS |
| AX-2024-005034 | TB-500 | KP | KP-2407-V6115 | Janoshik | 2024-Q4 | 99.29 | 3.80 | 90.3 | Buyer-sourced | 0 | PASS |